Investing.com - Financial Markets Worldwide

Radiopharm Theranostics receives $4.5 million R&D tax incentive

Published 16/07/2025, 13:18
Radiopharm Theranostics receives $4.5 million R&D tax incentive
RADX
0.64%

Radiopharm Theranostics Ltd (NASDAQ:RAD) announced Wednesday that it has received a research and development tax incentive of $4.5 million. The company disclosed the information in a statement released to the Australian Securities Exchange and included in a filing with the U.S. Securities and Exchange Commission.

The incentive is part of Australia’s R&D Tax Incentive program, which provides financial support to companies conducting eligible research and development activities in the country. Radiopharm Theranostics, headquartered in Carlton, Victoria, Australia, operates in the pharmaceutical preparations sector.

According to the filing, the announcement was authorized by company secretary Phillip Hains. No additional details regarding the use of funds or specific projects benefiting from the incentive were provided in the statement.

The information in this article is based on a press release statement included in the company’s SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.